Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 5:28 pm Purchase |
2024-12-31 | 13G | Lineage Cell Therapeutics, Inc. LCTX |
BLACKROCK INC BLK |
10,094,677 4.600% |
174,877 (+1.76%) |
Filing History |
| 2025-01-28 8:07 pm Purchase |
2025-01-27 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 57,848,357 24.500% |
15,789,474 (+37.54%) |
Filing History |
| 2024-11-21 8:05 pm Purchase |
2024-11-19 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 42,058,883 19.100% |
75,000 (+0.18%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Lineage Cell Therapeutics, Inc. LCTX |
BLACKROCK INC BLK |
9,919,800 5.300% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Lineage Cell Therapeutics, Inc. LCTX |
BLACKROCK INC BLK |
9,919,800 5.300% |
6,164,043 (+164.12%) |
Filing History |
| 2024-02-08 6:57 pm Purchase |
2024-02-06 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 41,983,883 22.200% |
6,756,610 (+19.18%) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Lineage Cell Therapeutics, Inc. LCTX |
BLACKROCK INC BLK |
3,755,757 2.200% |
-6,252,753 (-62.47%) |
Filing History |
| 2022-03-25 5:23 pm Purchase |
2022-03-10 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 35,227,273 20.700% |
980,106 (+2.86%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Lineage Cell Therapeutics, Inc. LCTX |
BLACKROCK INC BLK |
10,008,510 5.900% |
10,008,510 (New Position) |
Filing History |
| 2021-03-16 5:04 pm Purchase |
2021-03-11 | 13D | Lineage Cell Therapeutics, Inc. LCTX |
BROADWOOD PARTNERS LP | 34,247,167 21.200% |
34,247,167 (New Position) |
Filing History |
| 2021-01-08 5:00 pm Sale |
2021-01-07 | 13D | ASTERIAS BIOTHERAPEUTICS, INC. AST |
Lineage Cell Therapeutics Inc. LCTX |
3,297,401 4.900% |
-968,503 (-22.70%) |
Filing History |
| 2020-04-27 5:28 pm Sale |
2020-04-23 | 13D | ASTERIAS BIOTHERAPEUTICS, INC. AST |
Lineage Cell Therapeutics Inc. LCTX |
4,265,904 6.300% |
-1,775,250 (-29.39%) |
Filing History |